Keyphrases
Active Immunization
25%
Adoptive Transfer
50%
Antitumor Activity
25%
Breast Cancer
25%
Cancer Development
25%
Cancer Immunotherapy
25%
Cancer Vaccine
25%
Cellular Immune Response
25%
Epithelial Tumor
25%
Gene Products
25%
Host Reaction
25%
Immune Response
25%
Immunodominant Peptide
25%
Interleukin-2
25%
Lymphocytes
25%
Melanoma
25%
Metastatic Melanoma
25%
Ovarian Cancer
25%
Recombinant Virus
25%
Solid Cancer
100%
Tumor Antigen
50%
Tumor Regression
75%
Tumor Rejection
100%
Tumor-infiltrating Lymphocytes
100%
Vaccine Trial
25%
Medicine and Dentistry
Active Immunization
25%
Adoptive Transfer
50%
Antineoplastic Activity
25%
Breast Cancer
25%
Cancer Immunotherapy
25%
Cancer Vaccine
25%
Cellular Immunity
25%
Epithelioma
25%
Gene Product
25%
Immunotherapy
100%
In Vitro
25%
Interleukin 2
25%
Lymphocyte
25%
Malignant Neoplasm
100%
Metastatic Melanoma
25%
Nodular Melanoma
25%
Ovarian Cancer
25%
Tumor Antigen
50%
Tumor Infiltrating Lymphocyte
100%
Tumor Regression
75%
Tumor Rejection Antigen
100%
Virus Recombinant
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
25%
Breast Cancer
25%
Cancer Vaccine
25%
Epithelium Tumor
25%
Immunotherapy
100%
Interleukin 2
25%
Malignant Neoplasm
100%
Melanoma
25%
Metastatic Melanoma
25%
Neoplasm
100%
Ovary Cancer
25%
Tumor Antigen
50%
Tumor Regression
75%
Tumor Rejection Antigen
100%
Immunology and Microbiology
Active Immunization
25%
Adoptive Immunity
25%
Antineoplastic Activity
25%
Cancer Immunotherapy
25%
Cancer Vaccine
25%
Gene Product
25%
Immunotherapy
100%
Interleukin 2
25%
Lymphocyte
25%
Recombinant Virus
25%
Tumor Antigen
50%
Tumor Rejection Antigen
100%
Tumor-Associated Macrophage
100%
Nursing and Health Professions
Active Immunization
25%
Epithelium Tumor
25%
Tumor Rejection Antigen
100%
Virus Recombinant
25%